BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2021
View Archived Issues
Anelixis begins phase II study of immunomodulation with AT-1501 in islet cell transplant
Read More
Selexis and Pandion to advance development of PT-627
Read More
Ventyx initiates dosing in phase I study of VTX-958 for autoimmune diseases
Read More
CohBar selects CB5138-3 as lead candidate for IPF and other fibrotic diseases
Read More
FDA clears initiation of phase I study of Meissa's COVID-19 vaccine candidate MV-014-212
Read More
Therapeutics Solutions plans to use StemVacs to treat COVID-19
Read More
T-Cure enters clinical research agreement to support phase I study of KK-LC-1 TCR therapy
Read More
Updated interim data reported from phase I/II study of GTB-3550 TriKE
Read More
Induced blastocysts are model for earliest development stages
Read More
AbbVie presents first-in-human data for ABBV-3373
Read More
Immatics reports data updates from ongoing phase I studies of its ACTengine candidates
Read More
New results presented for oral formulation of milvexian
Read More
Phase III data for omidubicel versus standard UCB in high-risk hematologic malignancies
Read More
Chinese phase I study begins with LPM-3480392
Read More
Ide-cel induces responses in heavily pretreated patients with refractory/relapsed myeloma
Read More
Lipopolysaccharides induce neural repair sweet spot
Read More
Data flaws sink current AI models for COVID-19 diagnosis
Read More
High blood fats, sugars alter antigen processing
Read More
Translate Bio reports second interim analysis of phase I/II trial of MRT-5005 for cystic fibrosis
Read More
Phase III topline data reported from ARISE-3 trial of RGN-259 in dry eye
Read More
PDE4 inhibitors divulged by Hubei Bio-Pharmaceutical, Humanwell Healthcare
Read More
Hefei Institutes of Physical Sciences presents new PDGFR-alpha and/or PDGFR-beta inhibitors
Read More
New hydroxyacid oxidase 1 inhibitors discovered at OxaluRx
Read More
HBV caspid assembly inhibitors patented by Tibet Tiansheng Taifeng Pharmaceutical
Read More
Gilead describes compounds for Filoviridae virus infections
Read More